3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
13
Recruiting
3
Withdrawn
2
Unknown
2
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
13
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Uterine Cervical Neoplasms
131
Ovarian Neoplasms
108
Endometrial Neoplasms
81
Uterine Cervical Dysplasia
19
Papillomavirus Infections
17
Breast Neoplasms
17
Fallopian Tube Neoplasms
15
Carcinoma, Ovarian Epithelial
15
Colorectal Neoplasms
12
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Vulvar Neoplasms
10
Neoplasm Metastasis
10
Recurrence
9
Endometrial Hyperplasia
9
Cervical Cancer Screening
9
Prostatic Neoplasms
8
Acquired Immunodeficiency Syndrome
8
Uterine Neoplasms
7
Stomach Neoplasms
7
Squamous Intraepithelial Lesions
6
Locally Advanced Cervical Cancer
6
Anus Neoplasms
6
Vaginal Neoplasms
5
Sarcoma
5
Pancreatic Neoplasms
5
Melanoma
5
Lung Neoplasms
5
Head and Neck Neoplasms
5
Triple Negative Breast Neoplasms
4
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Laryngeal Neoplasms
×
Gynecologic
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled